洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

首页 临床进展 Clinical characteristics and outcomes of cancer patients and their hospital course during the COVID-19 pandemic in a developing country

【ChiCTR2300067424】Clinical characteristics and outcomes of cancer patients and their hospital course during the COVID-19 pandemic in a developing country

查看原文
立即下载
基本信息
登记号

ChiCTR2300067424

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2023-01-06

临床申请受理号

/

靶点

/

适应症

COVID-19

试验通俗题目

Clinical characteristics and outcomes of cancer patients and their hospital course during the COVID-19 pandemic in a developing country

试验专业题目

Clinical characteristics and outcomes of cancer patients and their hospital course during the COVID-19 infection

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

75300

联系人通讯地址
临床试验信息
试验目的

We aimed to compare the type and magnitude of COVID-19 clinical manifestations among cancer patients in our center to non-cancer COVID-19 affected patients.

试验分类
试验类型

队列研究

试验分期

回顾性研究

随机化

Not applicable

盲法

/

试验项目经费来源

None

试验范围

/

目标入组人数

28;71

实际入组人数

/

第一例入组时间

2020-03-08

试验终止时间

2020-10-26

是否属于一致性

/

入选标准

There were 99 patients evaluated during their COVID-19 disease course. This included 28 cancer patients and 71 non-cancer patients. All were COVID-19 PCR positive patients who were admitted to out facility.；

排除标准

Those patients who were managed outpatient or were suspected cases of COVID-19 but their PCT returned negative were excluded from the study.；

研究者信息
研究负责人姓名
试验机构

none

研究负责人电话
研究负责人邮箱
研究负责人邮编

75300

联系人通讯地址
<END>

none的其他临床试验

更多

Dow University of Health Sciences的其他临床试验

更多

最新临床资讯

更多
对摩熵医药数据库感兴趣，可以免费体验产品
体验产品

同适应症药物临床试验

更多